The research gap in chronic paediatric pain: A systematic review of randomised controlled trials

R Boulkedid1,2,3, A Y Abdou1, E Desselas4,5

  • 1AP-HP, Hôpital Robert Debré, Unité d'Epidémiologie Clinique, Paris, France.

Insights

Research on pain management for children and adolescents shows a significant gap in evaluating analgesics. Most studies focus on non-pharmacological methods and suffer from poor methodological quality, particularly for infants and younger children.

Area of Science:

  • Pediatric Pain Management
  • Clinical Trial Methodology
  • Evidence-Based Medicine

Background:

  • Chronic pain significantly impairs functioning and social engagement in children and adolescents.
  • There is a need to evaluate the quality and characteristics of research on pain management interventions for this population.

Purpose of the Study:

  • To assess the characteristics and methodological quality of randomized controlled trials (RCTs) for pain management in pediatric chronic pain patients.
  • To identify research gaps in the evaluation of pharmacological and non-pharmacological interventions.

Main Methods:

  • Systematic literature search of PubMed, Embase, and Cochrane Library up to July 2017.
  • Inclusion of RCTs involving children and adolescents (3 months–18 years) with chronic pain (persisting >3 months).
  • Methodological quality assessed using the Cochrane Risk of Bias (ROB) Tool.

Main Results:

  • 58 RCTs were identified, with increasing numbers over time.
  • Non-pharmacological interventions were predominantly tested; only 5 RCTs evaluated analgesics.
  • 90% of RCTs exhibited high or unclear risk of bias, indicating poor methodological quality.
  • Abdominal pain, headache/migraine, and musculoskeletal pain were common conditions.

Conclusions:

  • There is a marginal evaluation of analgesics for chronic pain in children and adolescents via RCTs.
  • Infants and children with long-lasting painful conditions are underrepresented in research.
  • Significant research gaps and methodological challenges exist in pediatric pain management trials.
Abstract